As the pharmaceutical giant received approval for valbenazine capsules from the US Food and Drug Administration (FDA), its shares soared by more than 5% on Friday. Adults with tardive dyskinesia, a medical condition that affects movement and facial tics like lip-smacking and grimacing, are treated with this medication. According to Lupin, the US FDA FDA […]
Continue Reading
The pharmaceutical company Lupin made the announcement that its alliance partner Caplin Steriles’ multiple-dose vials of Thiamine Hydrochloride injection USP, 200 mg/2 mL (100 mg/mL) had been granted approval by the United States Food and Drug Administration (US FDA). According to IQVIA MAT for the twelve months ending December 2022, sales of Thiamine Hydrochloride Injection […]
Continue Reading
The major pharmaceutical company made the announcement that its new drug application for Dolutegravir, Emtricitabine, and Tenofovir Alafenamide (DETAF) tablets had received preliminary approval from the US Food and Drug Administration (USFDA). DETAF tablets were tentatively approved by the US Food and Drug Administration as part of the President’s Emergency Plan to Fight AIDS (PEPFAR). […]
Continue Reading
On July 25, 2022, the US Food and Drug Administration (FDA) approved Azilsartan Medoxomil tablets, a generic hypertension drug developed by Lupin is used to treat hypertension or high blood pressure. The product is a generic equivalent of Edarbi tablets, 40 and 80 mg, developed by Azurity Pharmaceuticals, Inc., and the drug is mainly used […]
Continue Reading
On Friday, 6th May 2022, Lupin, pharmaceutical company announced that, it is now received the approval from the Food and Drug Administration (FDA) of the United States for the iloperidone and pregabalins tablets. The pregabalin capsules have been used for treating anxiety and epilepsy and as Iloperidone tablets have been used for the purpose of […]
Continue Reading
Lupin, a pharmaceutical company said, it has now received the approval from the US FDA (Food and Drug Administration) for the purpose of marketing the company’s generic version of Desvenlafaxine extended-release tablets that are used for the purpose of treating depression. The approval granted by the US FDA has been for the abbreviated new drug […]
Continue Reading
The pharmaceutical company ‘Lupin’ said that, the company has now received an approval from the Food and Drug Administration (FDA) of the United States for the Vigabatrin for the oral solution USP, and the approved ANDA (abbreviated new drug application) has been a generic equivalent of the Sabril for the oral solution of the company […]
Continue Reading
On Thursday, 27th January 2022, the pharmaceutical company ‘Lupin’ said that, it has now entered into an agreement with the company ‘Exeltis USA’ for the purpose of promoting the specialty antibacterial drug known as Solosec in the market of the United States. The company ‘Exeltis USA’ is going to be marketing the Solosec drug along […]
Continue Reading
The pharmaceutical company ‘Lupin’ said that, it has successfully received the approval from the Food and Drug Administration (FDA) of the United States for the company’s ANDA (abbreviated new drug application) Sevelamer Carbonate for the oral suspension. This drug or medicine has been a generic equivalent of the Renvela for the oral suspension produced by […]
Continue Reading
On Thursday, 1st July 2021, the pharmaceutical company ‘Lupin’ said, the company’s subsidiary based in the United States have received the approval from the health regulator of the United States of America for the company’s new supplemental drug application for the purpose of expanding the use of the drug ‘Solosec’ for the treatment of trichomoniasis, […]
Continue Reading